Charles L Paule is a notable inventor based in Westerville, Ohio. He has made significant contributions to the field of medical treatments, particularly in addressing diabetic ulcers. His innovative approach combines various compounds to enhance healing in diabetic individuals.

Latest Patents

Charles L Paule holds a patent for a unique combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. This combination is specifically designed for treating diabetic ulcers in individuals with certain health indicators. The patent discloses a method of treatment for diabetic ulcers in patients who have a serum albumin level of less than or equal to 4.0 g/dL and/or an Ankle-Brachial Index of less than 1.0. Additionally, the patent outlines the use of this combination for manufacturing a medicament aimed at treating diabetic ulcers.

Career Highlights

Paule is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work focuses on developing innovative solutions that improve patient outcomes, particularly for those suffering from diabetes-related complications.

Collaborations

Some of his notable coworkers include Jeffrey L Nelson and Anne C Voss. Their collaborative efforts contribute to the advancement of medical treatments and innovations within the company.

Conclusion

Charles L Paule's contributions to the field of medical treatment for diabetic ulcers highlight the importance of innovation in healthcare. His patented combination of compounds represents a significant step forward in improving the quality of life for diabetic patients.

Profile summary based on public USPTO records.